Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
NPJ Precision Oncology
|
May 30, 2026
Distinctive features of the tumor and immune microenvironment in glioblastoma
Elena Shklovskaya, Bernadette Pedersen, Su Yin Lim, et al.
Nature Communications
|
March 19, 2023
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny H Lee, et al.
Cancers
|
November 18, 2020
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
Elena Shklovskaya, Jenny H Lee, Su Yin Lim, et al.
Oncotarget
|
November 22, 2014
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
Serena Lunardi, Nigel B Jamieson, Su Yin Lim, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
Journal of Neurology
|
June 11, 2020
Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis
Soon Tjin Lim, Vincent Thijs, Stephen J X Murphy, et al.
International Journal of Cancer
|
May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Multiple Sclerosis and Related Disorders
|
March 28, 2024
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement
Shanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, et al.
Oncoimmunology
|
February 5, 2019
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients
Hansol Lee, Camelia Quek, Ines Silva, et al.
Cancer Cell
|
February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
NPJ Precision Oncology
|
May 30, 2026
Distinctive features of the tumor and immune microenvironment in glioblastoma
Elena Shklovskaya, Bernadette Pedersen, Su Yin Lim, et al.
Nature Communications
|
March 19, 2023
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny H Lee, et al.
Cancers
|
November 18, 2020
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
Elena Shklovskaya, Jenny H Lee, Su Yin Lim, et al.
Oncotarget
|
November 22, 2014
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
Serena Lunardi, Nigel B Jamieson, Su Yin Lim, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
Journal of Neurology
|
June 11, 2020
Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis
Soon Tjin Lim, Vincent Thijs, Stephen J X Murphy, et al.
International Journal of Cancer
|
May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Multiple Sclerosis and Related Disorders
|
March 28, 2024
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement
Shanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, et al.
Oncoimmunology
|
February 5, 2019
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients
Hansol Lee, Camelia Quek, Ines Silva, et al.
Cancer Cell
|
February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Page
of 7